FI942798A - Loracarbef-hydrokloridi-C1-C3-alkoholisolvaatit ja niiden käyttö - Google Patents

Loracarbef-hydrokloridi-C1-C3-alkoholisolvaatit ja niiden käyttö Download PDF

Info

Publication number
FI942798A
FI942798A FI942798A FI942798A FI942798A FI 942798 A FI942798 A FI 942798A FI 942798 A FI942798 A FI 942798A FI 942798 A FI942798 A FI 942798A FI 942798 A FI942798 A FI 942798A
Authority
FI
Finland
Prior art keywords
alcohol solvates
hydrochloride
loracarbef hydrochloride
loracarbef
disclosed
Prior art date
Application number
FI942798A
Other languages
English (en)
Swedish (sv)
Other versions
FI108134B (fi
FI942798A0 (fi
Inventor
Jane Goedde Amos
Perry Clark Heath
Douglas Edward Prather
John Eldon Toth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI942798A0 publication Critical patent/FI942798A0/fi
Publication of FI942798A publication Critical patent/FI942798A/fi
Application granted granted Critical
Publication of FI108134B publication Critical patent/FI108134B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI942798A 1993-06-15 1994-06-13 Loracarbef-hydrokloridi-C1-C3-alkoholisolvaatit ja menetelmä loracarbefin eristämiseksi FI108134B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/077,305 US5550231A (en) 1993-06-15 1993-06-15 Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US7730593 1993-06-15

Publications (3)

Publication Number Publication Date
FI942798A0 FI942798A0 (fi) 1994-06-13
FI942798A true FI942798A (fi) 1994-12-16
FI108134B FI108134B (fi) 2001-11-30

Family

ID=22137301

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942798A FI108134B (fi) 1993-06-15 1994-06-13 Loracarbef-hydrokloridi-C1-C3-alkoholisolvaatit ja menetelmä loracarbefin eristämiseksi

Country Status (13)

Country Link
US (2) US5550231A (fi)
EP (1) EP0629625B1 (fi)
JP (1) JP3474635B2 (fi)
KR (1) KR100310947B1 (fi)
AT (1) ATE225789T1 (fi)
BR (1) BR9402406A (fi)
CA (1) CA2125762A1 (fi)
DE (1) DE69431498T2 (fi)
ES (1) ES2184751T3 (fi)
FI (1) FI108134B (fi)
HU (1) HUT67489A (fi)
IL (1) IL109989A (fi)
TW (1) TW380139B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA978515B (en) * 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine
CA2506872A1 (en) * 2002-11-21 2004-06-03 Ranbaxy Laboratories Limited Monohydrate solvates of loracarbef
SI1603399T1 (sl) * 2003-03-12 2010-04-30 Lesaffre & Cie Pekovski kvas, njegova uporaba in pekovski izdelki, ki jih lahko pridobimo iz njega

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4316958A (en) * 1979-02-10 1982-02-23 Kyowa Hakko Kogyo Co., Ltd. Process for producing optically active cephalosporin analogs
JPS5672698A (en) * 1979-11-14 1981-06-16 Kyowa Hakko Kogyo Co Ltd Preparation of optically active cephalosporin analogue
US4332896A (en) * 1979-04-14 1982-06-01 Kyowa Hakko Kogyo Co., Ltd. Process for producing cephalosporin analogs
US4775751A (en) * 1985-06-03 1988-10-04 Eli Lilly & Company Process for cephalexin hydrochloride alcoholates
CA1334970C (en) * 1987-10-06 1995-03-28 Carol Elaine Pasini Crystalline .beta.-lactam hydrate
CA2002597C (en) * 1988-11-14 1999-03-23 Thomas M. Eckrich Solvates of b-lactam antibiotic
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
US4977257A (en) * 1988-11-14 1990-12-11 Eli Lilly And Company DMF solvates of a β-lactam antibiotic
CA2034592C (en) * 1990-01-26 2001-06-05 Ralph R. Pfeiffer Crystalline hydrochloride of new beta-lactam antibiotic and process therefor
US5057607A (en) * 1990-06-08 1991-10-15 Eli Lilly And Company Enantiomerically selective biocatalyzed acylation
US5374719A (en) * 1993-06-04 1994-12-20 Eli Lilly And Company Process for converting loracarbef dihydrate to loracarbef monohydrate
US5399686A (en) * 1993-06-04 1995-03-21 Eli Lilly And Company Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate
US5352782A (en) * 1993-06-04 1994-10-04 Eli Lilly And Company Process for preparing crystalline β-lactam monohydrate
US5412094A (en) * 1993-06-28 1995-05-02 Eli Lilly And Company Bicyclic beta-lactam/paraben complexes

Also Published As

Publication number Publication date
HU9401765D0 (en) 1994-09-28
DE69431498T2 (de) 2003-06-26
KR100310947B1 (ko) 2001-12-28
US5550231A (en) 1996-08-27
ATE225789T1 (de) 2002-10-15
EP0629625B1 (en) 2002-10-09
KR950000704A (ko) 1995-01-03
JP3474635B2 (ja) 2003-12-08
CA2125762A1 (en) 1994-12-16
IL109989A0 (en) 1994-10-07
TW380139B (en) 2000-01-21
US5578720A (en) 1996-11-26
FI108134B (fi) 2001-11-30
DE69431498D1 (de) 2002-11-14
BR9402406A (pt) 1995-01-17
IL109989A (en) 1998-06-15
EP0629625A1 (en) 1994-12-21
FI942798A0 (fi) 1994-06-13
JPH0770122A (ja) 1995-03-14
ES2184751T3 (es) 2003-04-16
HUT67489A (en) 1995-04-28

Similar Documents

Publication Publication Date Title
DK0657458T3 (da) Inhibitorer af proteinkinase-C
DK0773943T3 (da) Forbindelser, der er anvendelige som antiproliferative midler og garft-inhibitorer
DE69628804T2 (de) Substitutierte heterozyclische Derivate als CRF Antagonisten
FI101376B1 (fi) Menetelmä 3-bentsyyliamino-2-fenyylipiperidiinijohdannaisten valmistamiseksi
NZ228065A (en) 1,2,4-triazinediones and parasiticidal compositions; processes for preparation
SE8901032D0 (sv) Mellanprodukter foer framstaellning av karbapenemderivat
FI942798A (fi) Loracarbef-hydrokloridi-C1-C3-alkoholisolvaatit ja niiden käyttö
FI952420A (fi) Glukopyranosidibentsotiofeenit
DK104388A (da) Hidtil ukendte 2-(2,3-dihydro-2-oxo-3-benzofuranyl)-eddikesyrederivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem

Legal Events

Date Code Title Description
MA Patent expired